Sepsis Diagnostics Market Size Worth USD 1,255.14 Million by 2034 | CAGR of 7.00%

Polaris Market Research has released a new industry study estimating the global Sepsis Diagnostics Market at USD 682.72 million in 2025, with the market on track to touch USD 1,255.14 million by 2034 at a CAGR of 7.00% across the 2026-2034 forecast window.

Market Overview: Rapid Sepsis Diagnostics and Market Size
Sepsis is a life-threatening response to infection, and how quickly it is identified shapes patient outcomes. Sepsis testing spans instruments, blood culture media, assay kits and reagents, and software used across hospitals, emergency departments, ICUs, and reference laboratories to detect infection, gauge severity, and guide treatment. A rising sepsis burden and a stronger focus on early intervention are lifting demand. Market size is estimated at USD 729.14 million in 2026, and the market forecast points to USD 1,255.14 million by 2034. AI-based risk prediction is emerging as a complement to microbiology and molecular tests, not a replacement.

👉Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market

Key Market Insights
• North America held a 42.8% market share in 2025, backed by strong healthcare systems and early adoption of advanced diagnostics.
• Asia Pacific is projected to post the fastest market growth, at a CAGR of 10.7% during 2026-2034.
• Assay kits & reagents are expected to grow at a CAGR of 9.9%, supported by routine use in sepsis testing.
• Point-of-care sepsis testing generated 38.6% of 2025 revenue, valued for faster results and earlier treatment decisions.
• Microbiology accounted for 34.7% of 2025 revenue and remains widely used to identify disease-causing pathogens.

Market Dynamics: Drivers, Restraints and Opportunities
• Driver: Molecular sepsis testing, including PCR, NGS, and multiplex assays, detects pathogens and resistance markers faster than conventional culture.
• Driver: Biomarker-based sepsis testing, using procalcitonin, CRP, interleukins, and lactate, supports risk stratification and antimicrobial stewardship.
• Driver: Demand for bedside testing is rising as providers work to shorten time-to-treatment in emergency and critical care.
• Restraint: No single definitive test exists, and sepsis symptoms overlap with other infections, complicating diagnosis.
• Restraint: High system costs, limited laboratory access in developing regions, and a shortage of skilled professionals slow adoption.
• Opportunity: AI-enabled risk stratification and integrated platforms that pair testing with analytics and alerts are opening new revenue streams.

Market Segmentation: Product, Technology, Testing Type, End User and Pathogen
The study segments the market by product, technology, testing type, end user, and pathogen. By product, assay kits & reagents lead, while software is expected to grow fastest on rising digital adoption. By technology, microbiology holds the largest share, whereas molecular diagnostics is the fastest-growing category, alongside immunoassays and flow cytometry. Laboratory testing remains the larger testing channel, though point-of-care formats are expected to expand faster. Hospitals and clinics account for the largest end-user share, with pathology and reference laboratories growing quickest. By pathogen, bacterial sepsis, covering gram-positive and gram-negative infections, dominates, while fungal sepsis is a smaller but critical segment.

👉Inquire more about this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/pricing

Regional Insights: Market Share and Market Growth by Region
• North America: Largest region; the U.S. leads on strong clinical demand and innovation.
• Europe: Significant share, with Germany, the UK, and France benefiting from strong laboratory infrastructure and infection-control focus.
• Asia Pacific: Fastest-growing region; China, India, and Japan contribute as healthcare spending and access to testing improve.
• Latin America: Brazil, Mexico, and Argentina offer opportunities, with demand for affordable testing increasing.
• Middle East & Africa: Steady development in Saudi Arabia, the UAE, and South Africa, supported by healthcare investment.

Competitive Landscape: Key Players in Sepsis Detection
Key players profiled in the study include Thermo Fisher Scientific, Abbott Laboratories, BioMérieux, Danaher Corporation, Roche Diagnostics, Siemens Healthineers, BD, QIAGEN, Sysmex Corporation, Beckman Coulter, Hologic, LumiraDx, Cepheid, ACON Laboratories, and Vericel Corporation. Competition now turns on speed and ease of use as much as accuracy, with vendors building platforms that combine testing with result interpretation. Microbiology leaders rely on installed hospital relationships, molecular specialists on faster detection, and point-of-care innovators on portable formats.

Recent Developments
• June 2026: Bruker expanded its microbiology and sepsis diagnostics portfolio at ASM Microbe 2026, launching new molecular testing and rapid antimicrobial susceptibility testing (AST) solutions.
• May 2026: Bayesian Health received FDA 510(k) clearance for its AI-based Targeted Real-Time Early Warning System, developed by Johns Hopkins researchers, which flags sepsis up to 48 hours before clinical suspicion.
• April 2026: Volition announced a finger-prick lateral flow test for sepsis detection that uses a small capillary blood sample to support point-of-care diagnosis.
• January 2025: Inflammatix received U.S. FDA marketing authorization for its TriVerity molecular test system for patients with suspected acute infection or sepsis.

More Trending Latest Reports By Polaris Market Research:
Aesthetic Exosomes Market:
https://www.polarismarketresearch.com/industry-analysis/aesthetic-exosomes-market

Automated Cell Culture Market:
https://www.polarismarketresearch.com/industry-analysis/automated-cell-culture-market

Biologics Manufacturing Market:
https://www.polarismarketresearch.com/industry-analysis/biologics-manufacturing-market

Catheter Stabilization Devices Market:
https://www.polarismarketresearch.com/industry-analysis/catheter-stabilization-devices-market

Contact Us
Polaris Market Research & Consulting, Inc.
8 The Green Ste 19824, Dover, DE 19901, United States
USA: +1 929-297-9727
APAC: +91-9591254545
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

About Polaris Market Research & Consulting, Inc.
Polaris Market Research is a global market intelligence and consulting company dedicated to delivering in-depth business insights and actionable research. We specialize in providing syndicated reports, customized consulting solutions, and strategic advisory services across diverse industries including healthcare, chemicals, energy, automotive, technology, and consumer goods. Our research methodology combines quantitative data with qualitative expertise, ensuring our clients receive accurate market sizing, growth forecasts, competitive analysis, and emerging trend insights. With a commitment to transparency, data accuracy, and client satisfaction, Polaris Market Research has become a trusted partner to leading corporations, consulting firms, and government organizations worldwide. We help businesses make informed strategic decisions, mitigate risk, and identify new growth opportunities in rapidly evolving markets. Learn more at www.polarismarketresearch.com

This release was published on openPR.